Surveillance for vaccine-preventable diseases

Hanna M. Nohynek*, Elizbeth Miller

*Corresponding author for this work

    Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

    1 Citation (Scopus)


    Vaccines are one of the most cost-effective health intervention tools. When developing and before introducing a new vaccine, vaccine-preventable disease (VPD) data are required to estimate the burden of disease, to identify risk groups, and to decide on the appropriate vaccination or vaccine development strategy. Post-introduction data are required to monitor vaccine program performance, to identify remaining pockets of susceptible individuals, and to provide alert signals to identify and control outbreaks. Both clinical and laboratory-based data sources are used. If VPDs are not notifiable by law, and if surveillance data are not available via routine systems, special studies can be performed. Vaccine program-related surveillance includes coordinated monitoring of vaccine coverage and vaccine effectiveness by measuring VPD incidence, hospitalizations, deaths, and vaccine-related adverse events. Epidemiologic methods used are vaccine coverage and serosurveys, cluster sampling, case-control, and cohort studies. This edition first published 2013

    Original languageEnglish
    Title of host publicationInfectious Disease Surveillance
    Subtitle of host publicationSecond Edition
    PublisherJohn Wiley and Sons
    Number of pages13
    ISBN (Print)9780470654675
    Publication statusPublished - 12 Mar 2013


    • Case-control
    • Cluster sampling
    • Cohort study
    • Population assessment
    • Serosurveillance
    • Surveillance
    • Vaccine coverage
    • Vaccine effectiveness
    • Vaccine efficacy
    • Vaccine-preventable disease


    Dive into the research topics of 'Surveillance for vaccine-preventable diseases'. Together they form a unique fingerprint.

    Cite this